With a high rate of mortality, acute respiratory distress syndrome (ARDS) has limited treatments options. Immune-enhanced formulas, containing eicosapentaenoic acid, borage oil, and antioxidants, have shown to be beneficial in adults patients with ARDS, decreasing mortality, length of mechanical ventilation, and new organ dysfunction. There is promising research in pediatric patients with improvement in oxygenation status found, but further trials are needed to realize these benefits in pediatric and infant populations.
Verger JT, Bradshaw DJ, Henry E., Roberts KEThe pragmatics of feeding the pediatric patient with acute respiratory distress syndrome. Crit Care Nurs Clin North Am. 2004 ;16:431-443.
Bernard GR, Artigas A., Brigham KL, et al. The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med. 1994;149:818-824.
4.
Thomas NJ, Shaffer ML, Willson DF, Shih MC, Curley MADefining acute lung disease in children with the oxygenation saturation index . Pediatr Crit Care Med. 2010;11:12-17.
5.
Pontes-Arruda A., Demichele S., Seth A., Singer P.The use of an inflammation-modulating diet in patients with acute lung injury or acute respiratory distress syndrome: a meta-analysis of outcome data. JPEN J Parenter Enteral Nutr . 2008;32:596-605.
6.
Wheeler AP, Bernard GRAcute lung injury and the acute respiratory distress syndrome: a clinical review. Lancet. 2007;369:1553-1564.
7.
Ware LBPathophysiology of acute lung injury and the acute respiratory distress syndrome . Semin Respir Crit Care Med. 2006 ;27: 337-349.
8.
Weinacker AB , Vaszar LTAcute respiratory distress syndrome: physiology and new management strategies. Annu Rev Med. 2001; 52:221-237.
9.
Ware LB, Matthay MAThe acute respiratory distress syndrome. N Engl J Med. 2000;342:1334-1349.
10.
al-Saady NM , Blackmore CM, Bennett EDHigh fat, low carbohydrate, enteral feeding lowers PaCO2 and reduces the period of ventilation in artificially ventilated patients. Intensive Care Med. 1989 ;15:290-295.
11.
McClave SA, Martindale RG, Vanek VW, et al. Guidelines for the provision and assessment of nutrition support therapy in the adult critically ill patient: Society of Critical Care Medicine (SCCM) and American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) . JPEN J Parenter Enteral Nutr. 2009;33:277-316.
12.
Gadek J., DeMichele S., Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27: 1409-1420.
13.
Singer P., Theilla M., Fisher H., Gibstein L., Grozovski E., Cohen J.Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34:1033-1038.
14.
Pontes-Arruda A., Aragão AMA, Albuquerque JDEffects of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, and antioxidants in mechanically ventilated patients with severe sepsis and septic shock. Crit Care Med. 2006;34:2325-2333.
15.
Mizock BANutritional support in acute lung injury and acute respiratory distress syndrome . Nutr Clin Pract. 2001;16:319-328.
16.
Malone AMThe use of specialized enteral formulas in pulmonary disease. Nutr Clin Pract. 2004;19:557-562.
17.
Mizock BA, DeMichele SJThe acute respiratory distress syndrome: role of nutritional modulation of inflammation through dietary lipids. Nutr Clin Pract. 2004;19:563-574.
18.
Nadkarni V. , DeMichele SJ, Goldstein B., Checchia P., Ayad O., Jacobs BRSafety of an enteral formula enriched with eicosapentaenoic acid and gamma-linolenic acid in critically ill children with acute lung injury. Crit Care Med. 2005 ;33:A99.
19.
Briassoulis G., Filippou O., Hatzi E., Papassotiriou I., Hatzis T.Early enteral administration of immunonutrition in critically ill children: results of a blinded randomized controlled clinical trial. Nutrition. 2005;21:799-807.
20.
Mayes T., Gottschlich MM, Kagan RJAn evaluation of the safety and efficacy of an anti-inflammatory, pulmonary enteral formula in the treatment of pediatric burn patients with respiratory failure. J Burn Care Res. 2008 ;29:82-88.
21.
Zhou M., Martindale RGArginine in the critical care setting. J Nutr. 2007;137:1687S-1692S.
22.
Morris SM Jr.Arginine: beyond protein. Am J Clin Nutr . 2006;83: 508S-512S.
23.
Yu YM, Sheridan RL, Burke JF, Chapman TE, Tompkins RG, Young VRKinetics of plasma arginine and leucine in pediatric burn patients . Am J Clin Nutr. 1996;64:60-66.
24.
Yu YM, Ryan CM, Castillo L., et al. Arginine and ornithine kinetics in severely burned patients: increased rate of arginine disposal. Am J Physiol Endocrinol Metab. 2001;280:E509-E517.
25.
Argaman Z., Young VR, Noviski N., et al. Arginine and nitric oxide metabolism in critically ill septic pediatric patients. Crit Care Med. 2003;31:591-597.
26.
van Waardenburg DA, de Betue CT, Luiking YC, Engel M., Deutz NEPlasma arginine and citrulline concentrations in critically ill children: strong relation with inflammation. Am J Clin Nutr. 2007; 86:1438-1444.
27.
Mizock BAImmunonutrition and critical illness: an update. Nutrition . 2010;26:701-707.
Marik PE, Zaloga GPImmunonutrition in critically ill patients: a systematic review and analysis of the literature. Intensive Care Med. 2008 ;34:1980-1990.
30.
Marin VB, Rodriguez-Osiac L., Schlessinger L., Villegas J., Lopez M., Castillo-Duran C.Controlled study of enteral arginine supplementation in burned children: impact on immunologic and metabolic status. Nutrition. 2006;22:705-712.
31.
Levy J.Immunonutrition: the pediatric experience. Nutrition . 1998;14:641-647.
32.
Skillman HE , Wischmeyer PENutrition therapy in critically ill infants and children. JPEN J Parenter Enteral Nutr. 2008;32:520-534.
33.
Metha NM, Compher C; A.S.P.E.N. Board of Directors. A.S.P.E.N. clinical guidelines: nutrition support of the critically ill child. JPEN J Parenter Enteral Nutr. 2009;33:260-276.
